Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

News Daily News

DOACs Safe, Effective in Subset of Valvular AF Patients

Shelley Wood

March 31, 2021

News Daily News

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

Caitlin E. Cox

October 29, 2020

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

News Daily News

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Yael L. Maxwell

February 28, 2020

News Daily News

Potential Warning Signs Seen for NOAC Use After TAVR

Todd Neale

June 12, 2019

News Daily News

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

Todd Neale

January 09, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for January 2018

Shelley Wood

January 31, 2018

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Shelley Wood

September 13, 2016

News Daily News

Riesgo de ACV con TAVR: Una Revisión en Profundidad de los Datos del PARTNER y CoreValve Revela Oportunidades e Incógnitas

Shelley Wood

September 13, 2016

News Daily News

Tras la transfusión TAVR Atado a una Mayor Mortalidad

August 16, 2012

News Daily News

Post-TAVR Transfusion Tied to Increased Mortality

August 16, 2012

Advertisement

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

DOACs Safe, Effective in Subset of Valvular AF Patients

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Potential Warning Signs Seen for NOAC Use After TAVR

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

TCTMD’s Top 10 Most Popular Stories for January 2018

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Riesgo de ACV con TAVR: Una Revisión en Profundidad de los Datos del PARTNER y CoreValve Revela Oportunidades e Incógnitas

Tras la transfusión TAVR Atado a una Mayor Mortalidad

Post-TAVR Transfusion Tied to Increased Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content